The threat of acquiring infections in hospitals and healthcare facilities is a major concern for care providers and patients thus interest in infection control.

BOSTON, MASSACHUSETTS, U.S., February 7, 2017 /EINPresswire.com/ -- This report contains 186 market data tables and 47 figures spread through 454 pages and an exhaustive TOC on Products, End-users and geography.

Infection control is policies and procedures followed to minimize the threat of acquiring or spreading infections, especially in hospitals and healthcare facilities. Healthcare associated infection (HCAI) also known as nosocomial infection is the most common complications infection acquired as result of medical and surgical interventions or from being in contact with healthcare personnel or services and prevention and control of healthcare-associated infections remains a priority. The main purpose of infection control is to reduce the occurrence of infectious diseases via sterilization and disinfection technologies which are the essential components. High cleaning standards like hand hygiene, donning and doffing of personal protective equipment and use of sterilized medical devices in hospitals and clinics has triggered the growth of the medical sterilization and disinfection market which in-turn minimise the risk of acquiring HCAIs. As estimated by IQ4I Research, Infection Control global market is expected to grow at a single digit CAGR to reach $22,582 million by 2022.

Increase in aging population, rising occurrence of hospital acquired infections, increase in number of surgeries performed, proper maintenance of hygiene among hospital staff and increasing awareness among people are the factors driving the market growth. However, factors such as stringent regulations, economic downturn & saturation of market in developed countries and expensive ethylene oxide and gamma sterilization services are hampering the market growth.

The infection control market is mainly segmented into products, end-users and geography. Based on products the market is segmented into disinfection and sterilization. The infection control global market by geography is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America commanded the largest market share in 2015 due to high investments in healthcare infrastructures and demand for quality services are contributing for growth and is also projected to occupy largest market share. However, Asia-pacific region is expected to grow at the single digit highest CAGR during the forecast period due to, increased healthcare awareness, improved economic growth and increasing healthcare funding by the governments.

Companies such as Ansell Limited, Cantel Medical, Halyard Health, Hartmann, Sterigenics International Inc and Steris Corporation with large number of product offering, approval, acquisition and agreements are ahead of other companies and are considered to be leaders in the market. Xenex one of the major player in the rapidly emerging fields of robot UV disinfectors offers the Full Spectrum UV Germ-Zapping Robots also known as UV-C, this no-touch technology is highly energetic, extremely fast, portable and effective system in reducing microbial load. This instrument is developed and designed for allowing proven and systematic disinfection of any space within a healthcare facility via four primary mechanisms of cellular damage to prevent cell replication by photo-hydration, photo-splitting, photo-dimerization and photo crosslinking.

Major players in infection control market include, 3M Company (U.S.), Advanced Sterilization Products (U.S.), Ansell Limited (Australia), Belimed (Switzerland), Cantel Medical (U.S.), Getinge Group (Sweden), Halyard Health (U.S.), Hartmann Group (Germany), Sterigenics International Inc., (U.S.) and Steris Corporation (U.S.).

Mr. Satish Birudukota
IQ4I Research & Consultancy Pvt Ltd.,
+91-80-60500229
email us here